Kazia Therapeutics LimitedKazia Therapeutics LimitedKazia Therapeutics Limited

Kazia Therapeutics Limited

No trades
No trades

Compare with Kazia Therapeutics Limited


Market capitalization
‪124.10 M‬USD
−6.82USD
‪−13.41 M‬USD
‪27.20 K‬USD
‪9.83 M‬
Beta (1Y)
2.97
Next report date
Report period
EPS estimate
Revenue estimate

Company info


CEO
John E. Friend
Headquarters
Sydney
Founded
1994
ISIN
US48669G3039
CUSIP
48669G303
FIGI
BBG000KC7878
Identifiers
ISIN US48669G3039
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.